Nikhil Lalwani - 06 Mar 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Signature
/s/ Nikhil Lalwani, by attorney-in-fact Stephen P. Carey
Issuer symbol
ANIP
Transactions as of
06 Mar 2024
Net transactions value
-$4,129,541
Form type
4
Filing time
08 Mar 2024, 19:25:12 UTC
Previous filing
01 Mar 2024
Next filing
25 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $1,897,787 -28,965 -6.1% $65.52 444,981 06 Mar 2024 Direct F1
transaction ANIP Common Stock Tax liability $1,138,073 -17,060 -3.8% $66.71 427,921 07 Mar 2024 Direct F2
transaction ANIP Common Stock Sale $1,093,682 -16,292 -3.8% $67.13 411,629 08 Mar 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $65.00 to $66.01. The price reported above reflects the weighted average sales price.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 33,352 shares of restricted stock, the grant of which was previously reported.
F3 The shares were sold in multiple trades at prices ranging from $66.42 to $67.74. The price reported above reflects the weighted average sales price.